These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2746023)

  • 21. Delivery of ultraviolet-inactivated 35S-herpesvirus across an osmotically modified blood-brain barrier.
    Neuwelt EA; Pagel MA; Dix RD
    J Neurosurg; 1991 Mar; 74(3):475-9. PubMed ID: 1899695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amelioration of Experimental Autoimmune Encephalomyelitis in Mice by Interferon-Beta Gene Therapy, Using a Long-Term Expression Plasmid Vector.
    Hamana A; Takahashi Y; Tanioka A; Nishikawa M; Takakura Y
    Mol Pharm; 2017 Apr; 14(4):1212-1217. PubMed ID: 28257578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clearance of bilirubin from rat brain after reversible osmotic opening of the blood-brain barrier.
    Levine RL; Fredericks WR; Rapoport SI
    Pediatr Res; 1985 Oct; 19(10):1040-3. PubMed ID: 4058976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption.
    Yang W; Barth RF; Carpenter DE; Moeschberger ML; Goodman JH
    Neurosurgery; 1996 May; 38(5):985-92. PubMed ID: 8727825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pro-inflammatory cytokine interferon-gamma is an important driver of neuropathology and behavioural sequelae in experimental pneumococcal meningitis.
    Too LK; Ball HJ; McGregor IS; Hunt NH
    Brain Behav Immun; 2014 Aug; 40():252-68. PubMed ID: 24607660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilirubin-induced changes in brain energy metabolism after osmotic opening of the blood-brain barrier.
    Wennberg RP; Johansson BB; Folbergrová J; Siesjö BK
    Pediatr Res; 1991 Nov; 30(5):473-8. PubMed ID: 1754304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evans blue distribution in the rate brain after intracarotid injection with the blood-brain barrier intact and open to osmosis.
    Kozler P; Pokorný J
    Sb Lek; 2003; 104(3):255-62. PubMed ID: 15224531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intra-arterial chemotherapy of malignant glioma after osmotic blood-brain barrier disruption].
    Yamada K; Takahama H; Nakai O; Takanashi T; Hosoya T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2692-6. PubMed ID: 2506817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of interferon's antiviral activity by the mutually synergistic interaction of MuIFN-alpha/beta and MuIFN-gamma.
    Schwarz LA; Fleischmann CM; Fleischmann WR
    J Biol Response Mod; 1984 Dec; 3(6):608-12. PubMed ID: 6096507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodal investigations of trans-endothelial cell trafficking under condition of disrupted blood-brain barrier integrity.
    Marchi N; Teng Q; Nguyen MT; Franic L; Desai NK; Masaryk T; Rasmussen P; Trasciatti S; Janigro D
    BMC Neurosci; 2010 Mar; 11():34. PubMed ID: 20214812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study with positron emission tomography of the osmotic opening of the dog blood-brain barrier for quinidine and morphine.
    Agon P; Kaufman JM; Goethals P; Van Haver D; Bogaert MG
    J Pharm Pharmacol; 1988 Aug; 40(8):539-43. PubMed ID: 2907006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oromucosal interferon therapy: pharmacokinetics and pharmacodynamics.
    Eid P; Meritet JF; Maury C; Lasfar A; Weill D; Tovey MG
    J Interferon Cytokine Res; 1999 Feb; 19(2):157-69. PubMed ID: 10090401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon alpha/beta mediates early virus-induced expression of H-2D and H-2K in the central nervous system.
    Njenga MK; Pease LR; Wettstein P; Mak T; Rodriguez M
    Lab Invest; 1997 Jul; 77(1):71-84. PubMed ID: 9251680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of various methods for delivering radiolabeled monoclonal antibody to normal rat brain.
    Bullard DE; Bourdon M; Bigner DD
    J Neurosurg; 1984 Nov; 61(5):901-11. PubMed ID: 6436447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
    Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.
    Doolittle ND; Miner ME; Hall WA; Siegal T; Jerome E; Osztie E; McAllister LD; Bubalo JS; Kraemer DF; Fortin D; Nixon R; Muldoon LL; Neuwelt EA
    Cancer; 2000 Feb; 88(3):637-47. PubMed ID: 10649259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interleukins-1 alpha, -1 beta, and -2 do not acutely disrupt the murine blood-brain barrier.
    Banks WA; Kastin AJ
    Int J Immunopharmacol; 1992 May; 14(4):629-36. PubMed ID: 1521930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications.
    Rapoport SI
    Cell Mol Neurobiol; 2000 Apr; 20(2):217-30. PubMed ID: 10696511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.